Intra Cellular Therapies shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Intra Cellular Therapies
Tip: Access up to 7 years of quarterly data
All positions including Intra Cellular Therapies held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Intra Cellular Therapies by MetLife Investment Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $3.5M | 49k | 71.62 |
2023-09-30 | $2.6M | 49k | 52.09 |
2023-06-30 | $3.1M | 49k | 63.32 |
2023-03-31 | $2.6M | 48k | 54.15 |
2022-12-31 | $2.6M | 49k | 52.92 |
2022-09-30 | $2.3M | 49k | 46.53 |
2022-06-30 | $2.7M | 48k | 57.08 |
2022-03-31 | $2.6M | 43k | 61.19 |
2021-12-31 | $1.3M | 24k | 52.34 |
2021-09-30 | $987k | 27k | 37.28 |
2021-06-30 | $1.1M | 27k | 40.82 |
2021-03-31 | $898k | 27k | 33.93 |
2020-12-31 | $842k | 27k | 31.81 |
2020-09-30 | $679k | 27k | 25.66 |
2020-06-30 | $679k | 27k | 25.66 |
2020-03-31 | $358k | 23k | 15.37 |
2019-12-31 | $673k | 20k | 34.31 |
2019-09-30 | $147k | 20k | 7.47 |
2019-06-30 | $254k | 20k | 12.96 |
2019-03-31 | $239k | 20k | 12.18 |
2018-12-31 | $223k | 20k | 11.39 |
2018-09-30 | $663k | 31k | 21.71 |
2018-06-30 | $346k | 20k | 17.65 |
2018-03-31 | $413k | 20k | 21.06 |
2017-12-31 | $246k | 17k | 14.48 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors